Subject List - Pharmaceutical Executive

ADVERTISEMENT

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Site Content

ADVERTISEMENT

Catching Biopharmaceutical Sponsors by Surprise
Sandoz Wins Biosimilar Filing Race
Roche Reports Good Half-Year Performance
Pharm Exec's 2014 Dealmakers Outlook
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
PHARM EXEC DIGEST EUROPE
Pharmaceutical Executive Digest EuropeTo read the latest issue of Pharm Exec Global Digest
Click here. Click here to receive the Digest into your inbox every month.
SURVEY
The FDA Safety & Innovation Act (FDASIA) was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
16%
Protecting the supply chain
32%
Expedited reviews of drug submissions
16%
More stakeholder involvement
5%
View Results
Click here